跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,515 条关于
“MSN Pharma”
全部
14,515
临床试验
8,185
药物
1,592
机构
1,257
资讯
3,481
去年
Vanda Pharmaceuticals Appeals to FDA Commissioner Makary Over Generic Hetlioz Approvals Following Court Victory
去年
Appeals Court Denies Novartis' Bid to Block Generic Entresto, Threatening $5.6B Revenue Stream
9个月前
Supreme Court Declines Patent Case That Could Impact Heart Failure Drug Entresto and Pharmaceutical Innovation
去年
Novartis Loses Bid to Block Generic Entresto, J&J Cuts Neurology Programs
去年
Indian SEC Recommends Approval for MSN Laboratories' Pitolisant for Narcolepsy
2年前
Federal Court Denies Novartis Injunction Against Entresto Generic, Clearing Path for MSN Launch
7个月前
Major Pharmaceutical Patent Litigation Wave Intensifies in Q4 2025 as Generic Manufacturers Challenge Key Drug Patents
去年
Esperion Secures Patent Protection for NEXLETOL Until 2040 Through Settlement with Micro Labs
去年
Indian Patent Office Revokes Novartis' Vymada Patent, Opening Door for Generic Competition
上个月
SK Biopharm Settles US Patent Suit Over Xcopri, Reinforcing Long-Term Market Exclusivity
第 1 页,共 349 页
上一页
下一页